3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Prostatic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Melanoma
2
Lung Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Small Cell Lung Carcinoma
1
Sarcoma
1
Prostate Adenocarcinoma
1
Mesothelioma, Malignant
1
Lymphatic Metastasis
1
Carcinoma, Renal Cell
1
Carcinoma, Merkel Cell
1
Breast Carcinoma In Situ
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Taxes
2
Sunitinib
2
Paclitaxel
2
N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide
2
Carboplatin
2
vorolanib
1
selinexor
1
saracatinib
1
pembrolizumab
1
epacadostat
1
belinostat
1
amrubicin
1
Thymectomy
1
Robotic Surgical Procedures
1
Ramucirumab
1
Prednisone
1
Prednisolone
1
Pemetrexed
1
Nivolumab
1
NVP-BKM120
1
MK 2206
1
Lapatinib
1
Fentanyl
1
Erlotinib Hydrochloride
1
Doxepin
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Thymoma
×
Radiation Dose Hypofractionation
×
Clear all
No trials found.